These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32754266)
1. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation. Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266 [No Abstract] [Full Text] [Related]
2. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis. Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer. Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638 [TBL] [Abstract][Full Text] [Related]
4. A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer. Lu C; Ren C; Yang T; Sun Y; Qiao P; Wang D; Lv S; Yu Z Mol Cancer Res; 2020 May; 18(5):787-796. PubMed ID: 32041737 [TBL] [Abstract][Full Text] [Related]
5. Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer. Lu C; Qiao P; Sun Y; Ren C; Yu Z Clin Transl Med; 2021 Apr; 11(4):e400. PubMed ID: 33931981 [TBL] [Abstract][Full Text] [Related]
6. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Yang T; Ren C; Qiao P; Han X; Wang L; Lv S; Sun Y; Liu Z; Du Y; Yu Z Oncogene; 2018 Nov; 37(45):5997-6009. PubMed ID: 29985480 [TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer. Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y Biomed Pharmacother; 2016 Dec; 84():1144-1149. PubMed ID: 27780144 [TBL] [Abstract][Full Text] [Related]
8. Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity. Wang B; Zhou Y; Zhang J; Jin X; Wu H; Huang H Theranostics; 2020; 10(3):1033-1045. PubMed ID: 31938049 [No Abstract] [Full Text] [Related]
9. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway. Tang X; Cao T; Zhu Y; Zhang L; Chen J; Liu T; Ming X; Fang S; Yuan YF; Jiang L; Huang JD; Guan XY Cell Death Dis; 2020 Jul; 11(7):510. PubMed ID: 32641749 [TBL] [Abstract][Full Text] [Related]
10. Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer. Han X; Ren C; Yang T; Qiao P; Wang L; Jiang A; Meng Y; Liu Z; Du Y; Yu Z Oncogene; 2019 Sep; 38(38):6537-6549. PubMed ID: 31358902 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC. Han X; Ren C; Lu C; Jiang A; Wang X; Liu L; Yu Z Oncogene; 2024 Aug; 43(33):2493-2503. PubMed ID: 38969771 [TBL] [Abstract][Full Text] [Related]
12. Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer. Liu Y; Jiang Y; Wang N; Jin Q; Ji F; Zhong C; Zhang Z; Yang J; Ye X; Chen T Tumour Biol; 2017 Jun; 39(6):1010428317708779. PubMed ID: 28653874 [TBL] [Abstract][Full Text] [Related]
13. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo. Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983 [TBL] [Abstract][Full Text] [Related]
14. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance. Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021 [TBL] [Abstract][Full Text] [Related]
15. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Ryo A; Suizu F; Yoshida Y; Perrem K; Liou YC; Wulf G; Rottapel R; Yamaoka S; Lu KP Mol Cell; 2003 Dec; 12(6):1413-26. PubMed ID: 14690596 [TBL] [Abstract][Full Text] [Related]
16. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α. Shi L; He C; Li Z; Wang Z; Zhang Q Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159 [TBL] [Abstract][Full Text] [Related]
17. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα. Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826 [TBL] [Abstract][Full Text] [Related]
18. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells. Yu Z; Zhao X; Huang L; Zhang T; Yang F; Xie L; Song S; Miao P; Zhao L; Sun X; Liu J; Huang G J Biol Chem; 2013 Dec; 288(49):35406-16. PubMed ID: 24142698 [TBL] [Abstract][Full Text] [Related]
19. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma. Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541 [TBL] [Abstract][Full Text] [Related]
20. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. Madrid LV; Mayo MW; Reuther JY; Baldwin AS J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]